Delavirdine Mesylate Patent Expiration
Delavirdine Mesylate was first introduced by Viiv Healthcare Co
Delavirdine Mesylate Patents
Given below is the list of patents protecting Delavirdine Mesylate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Rescriptor | US6177101 | Delavirdine high strength tablet formulation |
Jun 07, 2019
(Expired) | Viiv Hlthcare |
| Rescriptor | US5563142 | Diaromatic substituted compounds as anti-HIV-1 agents |
Oct 08, 2013
(Expired) | Viiv Hlthcare |
Delavirdine Mesylate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List